Metadherin regulates radioresistance in cervical cancer cells

Oncology Reports

Volumn 27, Issue 5, 2012, Pages 1520-1526

  Zhao, Ying ^a   Moran, Meena S ^b   Yang, Qifeng ^a   Liu, Qiao ^c   Yuan, Cunzhong ^a   Hong, Shuhui ^d   Kong, Beihua ^a  

^a SHANDONG UNIVERSITY   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; DNA double strand breaks repair; Metadherin; Radiosensitivity

Indexed keywords

CELL PROTEIN; METADHERIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIOSENSITIVITY; REGULATORY MECHANISM; UTERINE CERVIX CANCER;

APOPTOSIS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; GENE SILENCING; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; RNA, SMALL INTERFERING; UTERINE CERVICAL NEOPLASMS;

EID: 84863259339     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1692     Document Type: Article

References (39)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Garland SM, Cuzick J, Domingo EJ, et al: Recommendations for cervical cancer prevention in Asia Pacific. Vaccine 26 (Suppl 12): M89-M98, 2008.
3. Nakano T, Kato S, Ohno T, et al: Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer 103: 92-101, 2005. (Pubitemid 39665461)
4. Nakano T, Ohno T, Ishikawa H, Suzuki Y and Takahashi T: Current advancement in radiation therapy for uterine cervical cancer. J Radiat Res (Tokyo) 51: 1-8, 2010.
5. Cochrane Gynaecological Cancer Group: Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Systematic Rev CD008285, 2010.
6. Noordhuis MG, Eijsink JJ, Roossink F, et al: Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo)radiation: a systematic review. Int J Radiat Oncol Biol Phys 79: 325-334, 2011.
7. Fuchs I, Vorsteher N, Buhler H, et al: The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma. Anticancer Res 27: 959-963, 2007. (Pubitemid 46587006)
8. Gaffney DK, Haslam D, Tsodikov A, et al: Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys 56: 922-928, 2003. (Pubitemid 36794022)
9. Kedzia W, Schmidt M, Frankowski A and Spaczynski M: Immunohistochemical assay of p53, cyclin D1, c-erbB2, EGFR and Ki-67 proteins in HPV-positive and HPV-negative cervical cancers. Folia Histochem Cytobiol 40: 37-41, 2002. (Pubitemid 34092366)
10. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354: 567-578, 2006. (Pubitemid 43209104)
11. Su ZZ, Kang DC, Chen Y, et al: Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 21: 3592-3602, 2002.
12. Su ZZ, Chen Y, Kang DC, et al: Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment. Gene 306: 67-78, 2003. (Pubitemid 36351396)
13. Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ and Fisher PB: Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 353: 8-15, 2005. (Pubitemid 40805356)
14. Hu G, Wei Y and Kang Y: The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res 15: 5615-5620, 2009.
15. Hu G, Chong RA, Yang Q, et al: MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15: 9-20, 2009.
16. Brown DM and Ruoslahti E: Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 5: 365-374, 2004. (Pubitemid 38482072)
17. Liu H, Song X, Liu C, Xie L, Wei L and Sun R: Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. J Exp Clin Cancer Res 28: 19, 2009.
18. Yoo BK, Emdad L, Su ZZ, et al: Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 119: 465-477, 2009.
19. Yu C, Chen K, Zheng H, et al:Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 30: 894-901, 2009.
20. Emdad L, Sarkar D, Lee SG, et al: Astrocyte elevated gene-1: a novel target for human glioma therapy. Mol Cancer Ther 9: 79-88, 2010.
21. Emdad L, Lee SG, Su ZZ, et al: Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci USA 106: 21300-21305, 2009.
22. O'Dwyer PJ, Stevenson JP and Johnson SW: Clinical pharmacokinetics and administration of established platinum drugs. Drugs 59 (Suppl 4): 19-27, 2000. (Pubitemid 30344988)
23. Osieka R and Schmidt CG: Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes. Klin Wochenschr 57: 1249-1258, 1979 (In German).
24. Friedl F, Kimura I, Osato T and Ito Y: Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology. Proc Soc Exp Biol Med 135: 543-545, 1970.
25. Hoeijmakers JH: Genome maintenance mechanisms for preventing cancer. Nature 411: 366-374, 2001.
26. Rogakou EP, Pilch DR, Orr AH, Ivanova VS and Bonner WM: DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858-5868, 1998. (Pubitemid 28124064)
27. Rothkamm K and Lobrich M: Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci USA 100: 5057-5062, 2003. (Pubitemid 36542657)
28. Bouquet F, Muller C and Salles B: The loss of γH2AX signal is a marker of DNA double strand breaks repair only at low levels of DNA damage. Cell Cycle 5: 1116-1122, 2006. (Pubitemid 43765309)
29. McKenna WG, Weiss MC, Endlich B, et al: Synergistic effect of the v-myc oncogene with H-ras on radioresistance. Cancer Res 50: 97-102, 1990. (Pubitemid 20030001)
30. Kong Z, Xie D, Boike T, et al: Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Cancer Res 70: 2829-2839, 2010.
31. Zerp SF, Stoter R, Kuipers G, et al: AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis. Radiat Oncol 4: 47, 2009.
32. Kobayashi J, Iwabuchi K, Miyagawa K, et al: Current topics in DNA double-strand break repair. J Radiat Res (Tokyo) 49: 93-103, 2008. (Pubitemid 351468636)
33. Thiriet C and Hayes JJ: Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair. Mol Cell 18: 617-622, 2005. (Pubitemid 40804798)
34. Foster ER and Downs JA: Histone H2A phosphorylation in DNA double-strand break repair. FEBS J 272: 3231-3240, 2005. (Pubitemid 40979296)
35. Essers J, van Steeg H, de Wit J, et al: Homologous and non-homologous recombination differentially affect DNA damage repair in mice. EMBO J 19: 1703-1710, 2000. (Pubitemid 30182176)
36. Hefferin ML and Tomkinson AE: Mechanism of DNA double-strand break repair by non-homologous end joining. DNA Repair (Amst) 4: 639-648, 2005. (Pubitemid 40720306)
37. Rothkamm K, Kruger I, Thompson LH and Lobrich M: Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 23: 5706-5715, 2003. (Pubitemid 36951334)
38. Jeggo PA and Lobrich M: Contribution of DNA repair and cell cycle checkpoint arrest to the maintenance of genomic stability. DNA Repair (Amst) 5: 1192-1198, 2006. (Pubitemid 44308466)
39. Van Dyck E, Stasiak AZ, Stasiak A and West SC: Binding of double-strand breaks in DNA by human Rad52 protein. Nature 398: 728-731, 1999. (Pubitemid 29197653)